PMID: 8972935Jan 1, 1996Paper

Secondary diagnoses as predictive factors for survival or mortality in Medicare patients with acute pneumonia

American Journal of Medical Quality : the Official Journal of the American College of Medical Quality
S R WhiteD Inczauskis

Abstract

We wished to determine if a claims-based method for severity adjustment would predict mortality or survival in pneumonia based on age, gender, and secondary diagnoses. We used a discriminant analysis model of severity of illness developed from Medicare Part A claims data. Our data base was taken from a hospitalized population age 65 years or older coded as DRG 89 (pneumonia with complications/comorbidities). There were 35,677 cases with a mortality = 11.2% in the derivation cohort from 1989 to 1990, and 19,915 cases with a mortality = 9.8% in the validation cohort from 1991. In the derivation cohort, 98% of patients predicted to live, lived, whereas 18% of patients predicted to die, died. Of the three variables, secondary diagnoses had greatest explanatory power. Receiver operating characteristic curves showed that the model performed best at 40% survival. Results were confirmed with the 1991 validation cohort. The model could be applied to hospitals with as few as 172 discharges. This simple, claims-based method can predict survival in pneumonia. It may be useful in selecting medical records for intensified review of medical quality.

References

Nov 1, 1992·Medical Care·H R Rubin, A W Wu
Apr 1, 1991·Statistics in Medicine·C Safran
Nov 1, 1991·Medical Care·D W SmithH Krakauer
Apr 1, 1991·Statistics in Medicine·C J McDonald, S L Hui
Jan 1, 1990·International Journal of Technology Assessment in Health Care·S DesHarnais
Jan 1, 1990·International Journal of Technology Assessment in Health Care·L I Iezzoni
Dec 1, 1990·American Journal of Public Health·E S FisherT A Bubolz
Jan 1, 1990·International Journal of Technology Assessment in Health Care·E P SteinbergG F Anderson
Mar 8, 1990·The New England Journal of Medicine·K N Lohr, S A Schroeder
Jan 5, 1989·The New England Journal of Medicine·D M Berwick
Sep 10, 1987·The New England Journal of Medicine·S F Jencks, A Dobson
Dec 1, 1988·Medical Care·S I DesHarnaisL F McMahon
Jan 1, 1987·Annual Review of Public Health·F A ConnellL G Hart
Jan 1, 1982·American Journal of Epidemiology·S Lemeshow, D W Hosmer
Feb 1, 1993·Annals of Internal Medicine·J ConcatoT R Holford
Feb 1, 1993·The American Journal of Medicine·M J FineW N Kapoor

❮ Previous
Next ❯

Citations

Jul 10, 2001·American Journal of Public Health·W B BaineJ P Summe
Sep 24, 2005·Medical Care Research and Review : MCRR·Paul L HebertRobert L Kane

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas
F S AbrãoF A Vasconcelos
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
C M Callahan, F D Wolinsky
© 2021 Meta ULC. All rights reserved